Key proteins in rare autoimmune disease identified
Antiphospholipid syndrome is an autoimmune disease that impacts about one in every 2,000 individuals.
Sep 10, 2025
0
11
Rheumatology news
Common arthritis drug found to lower blood pressure and risk of heart disease
Methotrexate, a common medication used to treat rheumatoid arthritis, has a newly recognized useful secondary effect of lowering blood pressure and potentially reduces the risk of heart disease in people with this condition.
Sep 3, 2025
0
26
Osteoporosis research: PEPITEM molecule shows promise in promoting bone growth and reducing bone loss
Researchers from the University of Birmingham, U.K., have identified bioactive peptide sequences in the PEPITEM molecule, and demonstrated the biological activity of the full PEPITEM molecule in counteracting key changes ...
Sep 2, 2025
0
26
Q&A: These genetic insights into rheumatoid arthritis could help design better treatments
People with rheumatoid arthritis (RA) often have trouble getting out of bed in the morning, let alone getting to the rheumatologist for a checkup or participating in a research study. This makes a deeper understanding of ...
Aug 28, 2025
0
13
Pregnancy brings unique challenges for people with autoimmune diseases
Only a few decades ago, a diagnosis of lupus could mean giving up the dream of having children. Women with systemic autoimmune diseases like lupus were warned that pregnancy was too risky—both for them and their unborn babies. ...
Aug 27, 2025
0
9
Benefits of long-term routine lab drug toxicity monitoring unclear in rheumatoid arthritis
For patients with rheumatoid arthritis (RA) using disease-modifying antirheumatic drugs (DMARDs), long-term routine laboratory toxicity monitoring (lt-RLTM) indicates that most very abnormal laboratory results are already ...
Aug 26, 2025
0
15
Back pain a $638 billion productivity black hole, Australian study warns
A new study from Monash University has revealed that long-term back problems will cost the Australian economy an estimated $638 billion in lost productivity over the next decade unless urgent action is taken.
Aug 25, 2025
0
16
FDA approves sublingual, nonopioid daily treatment for fibromyalgia
The U.S. Food and Drug Administration has approved Tonmya (cyclobenzaprine hydrochloride) sublingual tablets for the treatment of fibromyalgia in adults.
Aug 20, 2025
0
20
Researchers discover the immune system's 'fountain of youth'—though it comes at a price
The immune system is meant to protect the body from infection and disease. But with age, it can become less capable of doing so. However, Mayo Clinic researchers have found that some older people maintain "immune youth"—a ...
Aug 14, 2025
0
42
Could CAR-T therapy be a cure for lupus? Early trials show promise
Systemic lupus erythematosus (SLE) is a complex autoimmune disease with a spectrum of very different manifestations and variable severity.
Aug 8, 2025
0
18
